These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 312252)
41. Lymphocyte populations in chronic active liver disease: in vitro effect of levamisole on T-lymphocyte populations. Pozsonyi T; Fehér J; Jakab L Allergol Immunopathol (Madr); 1981; 9(1):37-44. PubMed ID: 6973266 [TBL] [Abstract][Full Text] [Related]
42. Inhibition of human T lymphocyte E rosette formation by neutrophils and hydrogen peroxide. Differential sensitivity between helper and suppressor T lymphocytes. Staite ND; Messner RP; Zoschke DC J Immunol; 1987 Oct; 139(7):2424-30. PubMed ID: 2958549 [TBL] [Abstract][Full Text] [Related]
43. Release of leukotrienes C4 and B4 and prostaglandin E2 from human monocytes stimulated with aggregated IgG, IgA, and IgE. Ferreri NR; Howland WC; Spiegelberg HL J Immunol; 1986 Jun; 136(11):4188-93. PubMed ID: 3009617 [TBL] [Abstract][Full Text] [Related]
44. Peritoneal exudate T lymphocytes with specificity to sheep red blood cells. IV. Fc receptors on specific peritoneal exudate lymphocytes and their role in delayed-type hypersensitivity reactions. Jabbar-S-Ahmed ; Kaufmann SH; Hahn H Immunology; 1981 Feb; 42(2):185-90. PubMed ID: 6970175 [TBL] [Abstract][Full Text] [Related]
45. Antibody penetration into living cells. II. Anti-ribonucleoprotein IgG penetrates into Tgamma lymphocytes causing their deletion and the abrogation of suppressor function. Alarcon-Segovia D; Ruiz-Arguelles A; Llorente L J Immunol; 1979 May; 122(5):1855-62. PubMed ID: 376727 [TBL] [Abstract][Full Text] [Related]
46. Restoration by levamisole of E-rosette formation and its abrogation by autochthonous serum from patients with bladder cancer. Akaza H; Yokoyama H; Umeda T; Niijima T Cancer; 1979 Jan; 43(1):97-100. PubMed ID: 761178 [TBL] [Abstract][Full Text] [Related]
47. Characterization of feline T and B cells. Kuramochi T; Takeishi M; Ishida T; Kato K; Ishida M Am J Vet Res; 1987 Feb; 48(2):183-5. PubMed ID: 3493718 [TBL] [Abstract][Full Text] [Related]
48. Human gamma interferon production by leukocytes induced with monoclonal antibodies recognizing T cells. von Wussow P; Platsoucas CD; Wiranowska-Stewart M; Stewart WE J Immunol; 1981 Sep; 127(3):1197-200. PubMed ID: 6167620 [TBL] [Abstract][Full Text] [Related]
49. Immunologic evaluation of rheumatoid arthritis and therapy with levamisole. Verhaegen H; de Cree J; de Cock W; Schuermans Y; Engels M; Sonck W Biomedicine; 1977 Jul; 26(4):283-91. PubMed ID: 922113 [TBL] [Abstract][Full Text] [Related]
50. [The use of levamisole (decaris) in patients with inoperable lung cancer]. Pivniuk VM; Kas'ianenko IV; Pivniuk NA Vopr Onkol; 1987; 33(5):82-6. PubMed ID: 3495925 [TBL] [Abstract][Full Text] [Related]
51. Lectin-induced thermostable SE-rosette (TSER) formation by human peripheral blood lymphocytes. Jahn S; Volk HD; Grunow R Allerg Immunol (Leipz); 1985; 31(3):195-201. PubMed ID: 2933939 [TBL] [Abstract][Full Text] [Related]
52. Inhibition of active E rosette forming T lymphocytes by hyaluronic acid. Evidence of a receptor for hyaluronic acid on a lymphocyte subpopulation. Chevrier A; Girard N; Delpech B; Gilbert D Biomed Pharmacother; 1982 Mar; 36(2):100-3. PubMed ID: 6982077 [TBL] [Abstract][Full Text] [Related]
53. Inhibition of the active E-rosette-forming T lymphocytes by a mesenchyme associated antigen. Chevrier A; Delpech B; Halavent C Biomedicine; 1980 Feb; 33(1):21-3. PubMed ID: 6966165 [TBL] [Abstract][Full Text] [Related]
54. Restoration by levamisole of rosette-forming cells inhibited by histamine, db-CAMP and adenosine. De Cock W; De Cree J; Verhaegen H J Immunopharmacol; 1978-1979; 1(1):115-22. PubMed ID: 233842 [TBL] [Abstract][Full Text] [Related]
55. Some T-cell functions in patients with viral myocarditis. The effect of levamisole. Goch JH; Czernicki J; Offierska M Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):395-404. PubMed ID: 6223612 [TBL] [Abstract][Full Text] [Related]
56. T gamma and T mu lymphocytes. Clinical and experimental studies of human T gamma and T mu lymphocytes participating in the immune response. Jensen JR Dan Med Bull; 1984 Apr; 31(2):73-89. PubMed ID: 6233103 [No Abstract] [Full Text] [Related]
57. The use of circulating rosette-forming cells as a guide to determination of ATG dose (dose-by-rosette). Byfield PE; Barth CL; Brodie JA; Cosimi AB; Dienst SG; Elberg AJ; Elfring GL; Hardy MA; Hayashi H; Kountz SL; Lamborn KR; Loughman BE; Sakai A; Satoh PS; Zielinski CM; Wechter WJ Transplant Proc; 1978 Sep; 10(3):627-31. PubMed ID: 362648 [No Abstract] [Full Text] [Related]
58. Reduced Fc-receptor bearing cells in peripheral bloods of patients with systemic lupus erythematosus and in rheumatoid synovial fluids. Nakai H; Morito T; Tanimoto K; Horiuchi Y J Rheumatol; 1977; 4(4):405-13. PubMed ID: 415139 [TBL] [Abstract][Full Text] [Related]
59. Fc receptors for IgA on human B, and human non-B, non-T lymphocytes. Lum LG; Muchmore AV; O'Connor N; Strober W; Blaese RM J Immunol; 1979 Aug; 123(2):714-9. PubMed ID: 313418 [TBL] [Abstract][Full Text] [Related]
60. [T-cell leukaemia with receptors for IgG Fc-fraction (author's transl)]. Mayans J; Prieto F; Martin G; Amigo V; Martínez J; Besalduch J; Sanz M; Marty ML Sangre (Barc); 1980; 25(2):227-30. PubMed ID: 6968095 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]